Genky DrugStores Co., Ltd.

9267.T
Pharmaceutical Retailers
2026/07/28 Updated
Market Cap: $735.6M (¥120.4B)
Stock Price: $24.13 (¥3,950)
Exchange Rate: 1 USD = ¥163.67

[Genky DrugStores] FY2025 Performance Trends and Store Strategy | July 2026

Genky DrugStores reports the trends in FY2025 sales, same-store sales, and customer visits, along with updates on store expansions, renovations, and closures. The company continues its store strategy into FY2026, closely monitoring sales and customer traffic movements.

Importance:
Page Updated: July 28, 2026
IR Disclosure Date: July 28, 2026

Key Figures

  • Sales (All Stores): 105.0% (YoY)
  • Same-store sales: 97.9% (YoY)
  • Number of stores: 534 stores (as of June 2026)

AI要約

Performance Overview

Genky DrugStores' FY2025 sales remained flat at 105.0% compared to the same period last year, while same-store sales declined slightly to 97.9%. The number of stores was maintained at 534, with no change from the previous period, despite opening new stores, renovations, and closures. The company is also monitoring trends in customer numbers and spend per customer, continuing efforts to improve performance.

Future Outlook and Strategy

In FY2026, the company plans to continue expanding and standardizing stores, aiming for stable growth in sales and customer traffic. It will proceed with opening new stores and renovations, strengthening a community-focused sales approach. Monitoring sales and customer trends, the company intends to work on improving profitability.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Genky DrugStores Corporation

Company overview · Stock price · Financial data · All IR

View company page →